X Facebook LinkedIn WhatsApp Press Releases (-) Any 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2015 April 13, 2015 arGEN-x N.V. Announces Changes to the Board of Directors April 8, 2015 arGEN-X Opens Expansion Cohort in Phase 1b Study of ARGX-111 in Patients with MET Amplified Cancers March 31, 2015 arGEN-X Announces Annual General Meeting of Shareholders 13 May 2015 March 17, 2015 arGEN-X Reports Fourth Quarter Business Update And Full Year 2014 Financial Results March 12, 2015 arGEN-X to Present at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference March 10, 2015 arGEN-X to Host Conference Call & Webcast to Report Fourth Quarter Business Update and Full Year 2014 Financial Results on March 18, 2015 March 3, 2015 arGEN-X Expands Preclinical Pipeline with ARGX-115: A Novel Simple Antibody™ for Cancer Immunotherapy March 1, 2015 arGEN-X Presents ARGX-111 at Targeted Anticancer Therapies February 17, 2015 Lonza and arGEN-X Announce a Multi-product GS Xceed™ License Agreement for Therapeutic Antibodies January 11, 2015 arGEN-X Launches Innovative Access Program 2014 December 10, 2014 arGEN-X Announces Advancement of Therapeutic Antibody Alliance with Shire December 7, 2014 arGEN-X Reports Preclinical Data on ARGX-110 in Chronic Myelogenous Leukemia Model Pagination First page « First Previous page ‹ Previous … Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Page 30 Page 31 … Next page Next › Last page Last »